01 February 2006
Management of hyperlipidemia: new LDL-C targets for persons at high-risk forcardiovascular events.
Med Sci Monit 2006; 12(2): RA34-39 :: ID: 445258
Abstract
Coronary heart disease (CHD) remains the leading cause of mortality inthe United States, and is associated with significant health care costs. Current evidence overwhelminglyconfirms the role of low-density lipoprotein cholesterol (LDL-C) in the pathogenesis of atherosclerosisand the risk of CHD events. The approach to the management of hyperlipidemia has evolved dramaticallyover the past decade. Randomized clinical trails have provided strong evidence that lowering plasma cholesterolwith statins reduces the risk of cardiovascular events, particularly in high-risk patients, irrespectiveof baseline cholesterol levels. The National Cholesterol Education Program (NCEP) report was releasedin July 2004. The report examined the results of recently concluded clinical trials and provided consensusrecommendations on the management of hyperlipidemia. The report expands on the core content of the previouslypublished guidelines. However, it is by far the most aggressive approach to date for reducing CHD risk.A focal element of the report is the modification of LDL-C goal in high-risk patients to
Keywords: Cholesterol, LDL - blood, Cardiovascular Diseases - prevention & control, Azetidines - administration & dosage, Cholestyramine Resin - administration & dosage, Clofibric Acid - administration & dosage, Drug Therapy, Combination, Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use, Hyperlipidemias - therapy, Hypolipidemic Agents - therapeutic use, Life Style, Niacin - administration & dosage, Risk Factors
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
14 Mar 2024 : Clinical Research
Differential DHA and EPA Levels in Women with Preterm and Term Births: A Tertiary Hospital Study in IndonesiaMed Sci Monit In Press; DOI: 10.12659/MSM.943895
15 Mar 2024 : Clinical Research
Evaluation of an Optimized Workflow for the Radiofrequency Catheter Ablation of Paroxysmal Atrial FibrillationMed Sci Monit In Press; DOI: 10.12659/MSM.943526
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952